Biological
mRNA-1010 influenza vaccine clinical trials
Also written mRNA-1010.
- studies test it
- 12
- open now
- 2
- in phase 3
- 4
- first study started
- 2021
Keep track of what changes. Save the mRNA-1010 influenza vaccine studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Development codes
Studies by the year they started
12 studies that test it; most in 2022 (6)
| Year | Studies |
|---|---|
| 2021 | 1 |
| 2022 | 6 |
| 2023 | 2 |
| 2024 | 1 |
| 2026 | 2 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 5
- Phase 2
- 4
- Phase 3
- 4
- Phase 4
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 12 · Other 0
Often tested with
Tested in the same studies.
2019-nCoV Vaccine mRNA-1273 (2) · mRNA-1345 respiratory syncytial virus vaccine (2) · MRNA-1045 (2) · mRNA-1647 cytomegalovirus vaccine (1) · mRNA-1273.214 COVID-19 vaccine (1) · MRNA-1230 (1) · mRNA-1073 COVID-19 and influenza combined vaccine (1)
Studies
Open first, then newest update. How each study uses mRNA-1010 influenza vaccine is read from its arms, and is right about nine times in ten.
Testing it · 12
- A Study of Updated mRNA Seasonal Influenza VaccinesNot yet recruitingPhase 4ModernaTX, Inc.NCT07884175Written as mRNA-1010
- A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1010 in Healthy ChildrenNot yet recruitingPhase 1ModernaTX, Inc.NCT07870330Written as mRNA-1010
- A Study of mRNA-1010 Compared With a Licensed Influenza Vaccine in Adults ≥50 Years of AgeCompletedPhase 3ModernaTX, Inc.NCT06602024Written as mRNA-1010
- A Study of Modified mRNA Vaccines in Healthy AdultsCompletedPhase 1ModernaTX, Inc.NCT05397223Written as mRNA-1010
- A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1010 in Healthy AdultsCompletedPhase 2ModernaTX, Inc.NCT05606965Written as mRNA-1010
- Study of mRNA-1010 Seasonal Influenza Vaccine in AdultsCompletedPhase 3ModernaTX, Inc.NCT05827978Written as mRNA-1010
- A Study of mRNA-1010 Seasonal Influenza Vaccine in Adults 50 Years Old and OlderCompletedPhase 3ModernaTX, Inc.NCT05566639Written as mRNA-1010
- Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA Vaccine Candidate Variations in Healthy AdultsCompletedPhase 2ModernaTX, Inc.NCT05868382Written as mRNA-1010
- A Study of mRNA-1010 Seasonal Influenza Vaccine in AdultsCompletedPhase 3ModernaTX, Inc.NCT05415462Written as mRNA-1010
- A Safety, Reactogenicity, and Immunogenicity Study of mRNA-1045 (Influenza and Respiratory Syncytial Virus [RSV]) or mRNA-1230 (Influenza, RSV, and Severe Acute Respiratory Syndrome Coronavirus 2 [SARS-CoV-2]) Vaccine in Adults 50 to 75 Years OldCompletedPhase 1ModernaTX, Inc.NCT05585632Written as mRNA-1010
- A Safety, Reactogenicity, and Immunogenicity Study of mRNA-1073 (COVID-19/Influenza) Vaccine in Adults 18 to 75 Years OldCompletedPhase 1/2ModernaTX, Inc.NCT05375838Written as mRNA-1010
- A Study of mRNA-1010 Seasonal Influenza Vaccine in Healthy AdultsCompletedPhase 1/2ModernaTX, Inc.NCT04956575Written as mRNA-1010
As the comparator · 2 — what is tested is compared with mRNA-1010 influenza vaccine
- A Study of mRNA-1011.1, mRNA-1011.2, and mRNA-1012.1 Candidate Seasonal Influenza Vaccines in Healthy AdultsCompletedPhase 1/2ModernaTX, Inc.NCT05827068Written as mRNA-1010
- A Study of mRNA-1020 and mRNA-1030 Seasonal Influenza Vaccines in Healthy AdultsCompletedPhase 1/2ModernaTX, Inc.NCT05333289Written as mRNA-1010
Codes
What other systems call mRNA-1010 influenza vaccine · ClinicalTrials.gg INT001886
- MeSH (NLM) C000722747mRNA-1010 influenza vaccineOne source ClinicalTrials.gov
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000722747 | mRNA-1010 influenza vaccine | One source ClinicalTrials.gov |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.